Upgrade to SI Premium - Free Trial

Notable 52-Week Highs and Lows 8/5: (MRK) (MTZ) (AZN) High; (CPSI) (BBRG) (APRI) Low

August 5, 2016 3:18 PM
52-Week High:Merck (NYSE: MRK) $62.98. Merck gaining as Bristol-Myers Squibb's CheckMate -026, phase 3 study of Opdivo for treatment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles